Abstract: In a semiconductor structure, a first conductive feature is formed in a trench by PVD and a glue layer is then deposited on the first conductive feature in the trench before CVD deposition of a second conductive feature there-over. The first conductive feature acts as a protection layer to keep silicide from being damaged by later deposition of metal or a precursor by CVD. The glue layer extends along the extent of the sidewall to enhance the adhesion of the second conductive features to the surrounding dielectric layer.

Abstract: A gait evaluating system including a processor is provided. The processor identifies whether a gait type of the user belongs to a normal gait, a non-neuropathic gait or a neuropathic gait based on step feature values of a user and walking limb feature values of the user. In response to that the gait type of the user belongs to the non-neuropathic gait, the processor controls the display panel to display a first auxiliary information, a second auxiliary information, and a third auxiliary information. The first auxiliary information indicates a potential sarcopenia of the user. The second auxiliary information indicates a dietary guideline for muscle building and muscle strengthening. The third auxiliary information shows a motion instruction video for regaining or maintaining muscle strength of the user.

Abstract: An isolated bacterial strain of Lactiplantibacillus plantarum subsp. plantarum MFM 30-3 deposited under the DSMZ Accession No. DSM 34213 is provided; a probiotic composition including an Lactiplantibacillus plantarum subsp. plantarum MFM 30-3 and optionally, one or more additional probiotic organisms that enhance the probiotic activity of the Lactiplantibacillus plantarum subsp. plantarum MFM 30-3 is also provided; and a method for preventing or treating chronic kidney disease in a subject in need thereof including: administering to the subject a pharmaceutically effective amount of the probiotic composition including an isolated bacterial strain of Lactiplantibacillus plantarum subsp. plantarum MFM 30-3, and optionally, one or more additional probiotic organisms that enhance the probiotic activity of the Lactiplantibacillus plantarum subsp. plantarum MFM 30-3 is further provided.

Abstract: A foldable stand for supporting a display panel of a display includes a base and two wings. The base includes a main body and two buttresses that extend downwardly from a bottom end of the main body so as to cooperate with the main body to define a recess thereamong. Each of the wings has a pivot part that extends into the recess and that is pivoted to the main body so as to permit the wings to be rotatable relative to the main body between a first position, in which the wings extend laterally and oppositely from the main body so as to be adapted to stand on a reference surface together with the buttresses, and a second position, in which the wings are folded together and extend downwardly from the main body.

Abstract: The present invention provides for methods and compounds for treating brain trauma and disorders such as: ischemia, stroke, neurodegenerative disorders, opioid addiction, idiopathic pain, epilepsy, and depression. More specifically, the invention provides methods for designing and identifying inhibitors of mammalian agmatinase and for compounds identified by these methods.

Abstract: A foldable stand for supporting a display panel of a display includes a base and two wings. The base includes a main body and two buttresses that extend downwardly from a bottom end of the main body so as to cooperate with the main body to define a recess thereamong. Each of the wings has a pivot part that extends into the recess and that is pivoted to the main body so as to permit the wings to be rotatable relative to the main body between a first position, in which the wings extend laterally and oppositely from the main body so as to be adapted to stand on a reference surface together with the buttresses, and a second position, in which the wings are folded together and extend downwardly from the main body.

Abstract: The present invention provides for methods and compounds for treating brain trauma and disorders such as: ischemia, stroke, neurodegenerative disorders, opioid addiction, idiopathic pain, epilepsy, and depression. More specifically, the invention provides methods for designing and identifying inhibitors of mammalian agmatinase and for compounds identified by these methods.